Reich K, Papp K, Blauvelt A, Langley R, Armstrong A, Warren R, Gordon K, Merola J, Madden C, Wang M, Vanvoorden V, Lebwohl M. Efficacy and Safety of Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Results from BE VIVID, a 52-Week Phase 3, Randomized, Double-Blinded, Ustekinumab- and Placebo-Controlled Study. J of Skin [Internet]. 2020 Oct. 27 [cited 2024 Jul. 3];4(6):s82. Available from: https://jofskin.org/33014/index.php/skin/article/view/1115